January 19, 2026 a 11:43 am
ZBH: Fundamental Ratio Analysis - Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. is engaged in the musculoskeletal healthcare sector, offering products for orthopedic reconstruction and other medical needs. Despite ongoing market fluctuations, ZBH has shown consistent performance in its core areas, backed by robust technological and infrastructural innovations. Overall, ZBH remains a reliable entity in its sector with a steady outlook.
Fundamental Rating
ZBH's fundamental analysis presents a mixed score with strengths in DCF and P/B ratios.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 4 |
Historical Rating
The historical data indicates consistent scoring in key areas, suggesting stable performance over recent fiscal periods.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-01-16 | 3 | 5 | 3 | 3 | 1 | 2 | 4 |
| N/A | 0 | 5 | 3 | 3 | 1 | 2 | 4 |
Analyst Price Targets
Analyst expectations show a balanced viewpoint with price targets indicating modest growth potential.
| High | Low | Median | Consensus |
|---|---|---|---|
| $130 | $93 | $110 | $108.91 |
Analyst Sentiment
Current analyst sentiment points towards holding, with a significant number of analysts rating it as 'Buy'.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 18 | |
| Hold | 20 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Zimmer Biomet Holdings, Inc. remains a fundamentally stable company with solid performance in discounted cash flow and price-to-book categories. Despite current market volatility and stronger competition, the stock represents a balanced investment primarily suggested as "Hold" by analysts. Future opportunities are anchored in continued innovation and robust sector presence, though debt ratios remain a concern. Investors should weigh the inherent risks against the promising dynamics within the healthcare market.